Institutional Ownership Eye Point Pharmaceuticals, Inc. (EYPT)
This table provides information about the institutional ownership of Eye Point Pharmaceuticals, Inc. (EYPT). We have compiled data on the 156 institutions that hold shares in the stock, with a total of 72.4 Million shares, which have been reported (via 13F filing form) to have a value of $451 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Cormorant Asset Management, LP
Boston, MA |
Feb 14, 2025 Q4 2024 |
8,325,000
shares
|
$52.2 Million
4.9% of portfolio
|
Q2 2024
Added 20.77%
|
|
Suvretta Capital Management, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
6,783,091
shares
|
$42.5 Million
2.1% of portfolio
|
Q4 2024
Added 31.05%
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Feb 14, 2025 Q4 2024 |
5,750,000
shares
|
$36.1 Million
0.08% of portfolio
|
Q4 2024
Added 51.66%
|
|
Franklin Resources Inc
San Mateo, CA |
Feb 12, 2025 Q4 2024 |
4,137,567
shares
|
$25.9 Million
0.01% of portfolio
|
Q4 2024
Added 3.13%
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
3,803,227
shares
|
$23.8 Million
0.0% of portfolio
|
Q4 2024
Added 24.77%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
3,764,881
shares
|
$23.6 Million
0.0% of portfolio
|
Q2 2024
Added 35.07%
|
|
Federated Hermes, Inc.
Pittsburgh, PA |
Feb 13, 2025 Q4 2024 |
3,707,445
shares
|
$23.2 Million
0.06% of portfolio
|
Q4 2024
Added 92.73%
|
|
Tcg Crossover Management, LLC
Palo Alto, CA |
Feb 14, 2025 Q4 2024 |
3,572,335
shares
|
$22.4 Million
4.35% of portfolio
|
Q4 2024
Added 287.31%
|
|
Ra Capital Management, L.P.
Boston, MA |
Feb 14, 2025 Q4 2024 |
3,181,818
shares
|
$19.9 Million
0.38% of portfolio
|
Q4 2024
New holding
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
2,466,866
shares
|
$15.5 Million
0.0% of portfolio
|
Q4 2024
Added 75.28%
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
2,144,747
shares
|
$13.4 Million
0.0% of portfolio
|
Q4 2024
Reduced 13.94%
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
1,662,421
shares
|
$10.4 Million
0.0% of portfolio
|
Q4 2024
Added 36.79%
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
1,538,902
shares
|
$9.65 Million
0.0% of portfolio
|
Q4 2024
Added 28.34%
|
|
Perceptive Advisors LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
1,537,274
shares
|
$9.64 Million
0.38% of portfolio
|
Q4 2024
Added 48.2%
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
1,491,667
shares
|
$9.35 Million
0.0% of portfolio
|
Q4 2024
Added 22.68%
|
|
Patient Square Capital LP
Menlo Park, CA |
Feb 14, 2025 Q4 2024 |
1,410,331
shares
|
$8.84 Million
3.93% of portfolio
|
Q4 2024
Added 3.55%
|
|
Essex Woodlands Management, Inc.
The Woodlands, TX |
Feb 13, 2025 Q4 2024 |
1,169,857
shares
|
$7.34 Million
2.01% of portfolio
|
Q4 2024
Reduced 24.6%
|
|
Finepoint Capital LP
Boston, MA |
Feb 13, 2025 Q4 2024 |
1,111,104
shares
|
$6.97 Million
0.7% of portfolio
|
Q4 2024
Added 57.07%
|
|
5 Am Venture Management, LLC
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
1,050,000
shares
|
$6.58 Million
3.47% of portfolio
|
Q3 2024
Added 2000.0%
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
Feb 14, 2025 Q4 2024 |
857,853
shares
|
$5.38 Million
0.02% of portfolio
|
Q4 2024
Added 90.08%
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
745,395
shares
|
$4.67 Million
0.0% of portfolio
|
Q4 2024
Reduced 58.96%
|
|
Blue Owl Capital Holdings LP
New York, NY |
Feb 14, 2025 Q4 2024 |
667,594
shares
|
$4.19 Million
2.13% of portfolio
|
Q4 2024
New holding
|
|
Bank Of America Corp
Charlotte, NC |
Feb 14, 2025 Q4 2024 |
648,030
shares
|
$4.06 Million
0.0% of portfolio
|
Q4 2024
Added 28.84%
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
643,157
shares
|
$4.03 Million
0.0% of portfolio
|
Q4 2024
Added 36.32%
|
|
Nantahala Capital Management, LLC
New Canaan, CT |
Feb 14, 2025 Q4 2024 |
600,000
shares
|
$3.76 Million
0.22% of portfolio
|
Q4 2024
New holding
|